Investor Relations

Company Overview

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system.

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Stock Snapshot

Investor Contact Information

Company

Calyxt, Inc.
2800 Mount Ridge Road
Roseville, MN 55113

Investor Relations

Argot Partners
Kimberly Minarovich
Cameron Willis
T: 212-600-1902
investors@calyxt.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
1155 Long Island Avenue
Edgewood, NY 11717
T: 1-877-830-4932
https://www.broadridge-ir.com/resources/transfer-agent/default.aspx